An Open-Label, Expanded Access Protocol of Iniparib Breast Cancer
Status: NO_LONGER_AVAILABLE
Study type: EXPANDED_ACCESS
Conditions: Breast Cancer
Interventions: DRUG: iniparib
Sponsor: Sanofi